A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults.
Saved in:
| Title: | A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults. |
|---|---|
| Authors: | Kao CM; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Rostad CA; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Nolan LE; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Peters E; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Kleinhenz J; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Sherman JD; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Tippett A; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Shih JWK; Xiamen Innovax Biotech Company Limited, Xiamen, China., Yildirim I; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Agbakoba V; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Beresnev T; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Ballou C; The Emmes Company, LLC, Rockville, Maryland, USA., Kamidani S; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Karmali V; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Natrajan M; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Scherer EM; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Rouphael N; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Anderson EJ; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2024 Nov 15; Vol. 230 (5), pp. 1093-1101. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6613 |
|---|---|
| DOI: | 10.1093/infdis/jiae148 |
